Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1722930
PUBLISHER: IMARC | PRODUCT CODE: 1722930
Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global blood plasma derivatives market size was valued at USD 48.27 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 75.9 Billion by 2033, exhibiting a CAGR of 5.2% from 2025-2033. North America currently dominates the market, holding a market share of over 48.9% in 2024. The rising chronic disease prevalence, advanced plasma collection infrastructure, technological innovations, growing geriatric population, and expanding therapeutic applications are some of the factors driving the market growth in this region.
Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.
Blood Plasma Derivatives Market Trends:
The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.
Key Market Segmentation:
Breakup by Type:
- Albumin
- Factor VIII
- Factor IX
- Immunoglobulin
- Hyperimmune Globulin
- Others
Breakup by Application:
- Hemophilia
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- Von Willebrand's Disease
- Others
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report
- 1.What are blood plasma derivatives?
- 2.How big is the blood plasma derivatives market?
- 3.What is the expected growth rate of the global blood plasma derivatives market during 2025-2033?
- 4.What are the key factors driving the global blood plasma derivatives market?
- 5.What is the leading segment of the global blood plasma derivatives market based on type?
- 6.What is the leading segment of the global blood plasma derivatives market based on application?
- 7.What is the leading segment of the global blood plasma derivatives market based on end user?
- 8.What are the key regions in the global blood plasma derivatives market?
- 9.Who are the key players/companies in the global blood plasma derivatives market?
Product Code: SR112025A5371
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Blood Plasma Derivatives Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Albumin
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Factor VIII
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Factor IX
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Immunoglobulin
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Hyperimmune Globulin
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Application
- 7.1 Hemophilia
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Hypogammaglobulinemia
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Immunodeficiency Diseases
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Von Willebrand's Disease
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Baxter International Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Bayer AG
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 CSL Limited
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Fusion Health Care Pvt. Ltd.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Grifols S.A.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Kedrion S.p.A.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 LFB S.A.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Octapharma AG
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 SWOT Analysis
- 14.3.9 Sanofi S.A.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Takeda Pharmaceutical Company Limited
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Baxter International Inc.
Product Code: SR112025A5371
List of Figures
- Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
- Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2024
- Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2024
- Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2024
- Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2024
- Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
- Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2024
- Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
- Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
- Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million USD), 2025-2033
- Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million USD), 2025-2033
- Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
- Table 7: Global: Blood Plasma Derivatives Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.